Founding Partners

Institute of Innovation and Entrepreneurship at London Business School  

The Institute’s mission is to have a profound impact on the way the world does business, and the way business impacts the world, by inspiring innovators and entrepreneurs and equipping them with the expertise and insight to drive growth. They also help organisations and businesses leaders by developing talented people and creating a global knowledge community. Their work focuses on the four pillars of research and activity, viz, developing brave new workplace, redesigning services, transforming lives through entrepreneurship and through enriching the entrepreneur’s journey.

LBS_Healthcare_Club_RGB_block.jpg

Healthcare Club at London Business School

The Healthcare Club is a student organisation that aims to promote all aspects of the healthcare sector, including digital health, the pharmaceutical industry, biotechnology, medical devices, and healthcare provision. With over 1500 student, alumni & faculty members, the club is one of the most active professional societies on campus. Our members come from a wide range of backgrounds including entrepreneurship, industry, consulting, banking, venture capital & private equity. The Club's objectives are to create Educational, Networking, and Recruitment opportunities for its members, and to promote London Business School as a hub for healthcare.

Health Tech Challenge Sponsors

Illumina logo.png

Illumina

Illumina, Inc. is the global leader in genomics, an industry positioned between biology and technology that enables the reading and understanding of genetic variations. Specifically, Illumina develops, produces and sells integrated devices and services for genome sequencing.

The company helped in creating the first map of gene variations associated with health, diseases and drug response. As part of its extraordinary development effort, Illumina gave a substantial contribution in reducing the costs of human genome sequencing bringing it to approximately 1,000$ (2014) from an initial cost of 1,000,000$ (2007).

Novartis

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales.

Novartis develops, manufactures and markets innovative medicines, devices and diagnostic tests which help improve patient outcomes.

 

Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products. From beginnings in the production of synthetic fabric dyes, the companies that eventually became Novartis branched out into producing chemicals and ultimately pharmaceuticals.

  • Black Facebook Icon
  • Black LinkedIn Icon

Copyright © 2021  The Healthtech Challenge. All Rights Reserved.